Tag: raw materials

Assessing Risks from Suboptimal Excipient Selection During Supplier Qualification In the context of pharmaceutical manufacturing, the selection of excipients plays a critical role in ensuring the safety, efficacy, and quality…

Addressing Improper Excipient Selection to Avert Late-Stage Reformulation Issues In pharmaceutical development, the choice of excipient is critical to the success of a formulation. However, unjustified excipient choices can lead…

Exploring the Investigation Process for Functional Performance Failures in Supplier Qualification In the pharmaceutical manufacturing industry, ensuring the quality and compatibility of raw materials, especially excipients, is paramount. Functional performance…

Overlooking Moisture Sensitivity in Stability Assessments: An Investigation Framework In the pharmaceutical manufacturing landscape, ensuring the quality and stability of both active pharmaceutical ingredients (APIs) and excipients is paramount. A…

Addressing Moisture Sensitivity Issues During Scale-Up to Avoid Late-Stage Reformulation In pharmaceutical manufacturing, the transition from small-scale to full-scale production is critical, yet it can expose previously unnoticed issues related…

Assessing Variability in Excipient Grades During Regulatory Review Variability in excipient grade during regulatory review can pose significant challenges for pharmaceutical companies, impacting both the approval process and product quality.…

Addressing Excipient Grade Variability During Supplier Qualification: A Comprehensive Investigation Approach Variability in excipient grade during supplier qualification can severely impact formulation performance and stability, potentially leading to significant deviations,…

Investigation into Supplier Grade Substitution During Scale-Up: Addressing Formulation Failures During the scale-up process within pharmaceutical manufacturing, the substitution of raw materials, particularly excipients, can lead to unexpected formulation failures.…

Examining Excipient Incompatibility with API During Scale-Up: Navigating Regulatory Scrutiny The challenge of excipient incompatibility with active pharmaceutical ingredients (API) during scale-up is a growing concern in the pharmaceutical industry.…

Implications of Unjustified Excipient Selection in Stability Assessments The selection of excipients for pharmaceutical formulations is critical to ensuring drug quality and efficacy. However, unjustified choices in excipient selection during…

Addressing Unjustified Excipient Selection During Stability Assessment In the pharmaceutical industry, the selection of excipients during formulation development is critical, particularly during stability assessments. Choosing an inappropriate excipient can adversely…

Understanding Excipient Incompatibility with APIs During Stability Assessments: An Investigation Approach Excipient incompatibility with active pharmaceutical ingredients (APIs) during stability assessments is a critical issue that can jeopardize product quality…